[1] |
Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol,2008,86:126-145.
|
[2] |
Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol,1979, 63:674-677.
|
[3] |
Gilbert CM, Owens SL, Smith PD, et al. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol,1984,68:815-820.
|
[4] |
Ladas ID, Rouvas AA, Apostolopoulos M, et al. Diffuse retinal pigment epitheliopathy: treatment with laser photocoagulation. Eur J Ophthalmol,2004,14:315-320.
|
[5] |
Ficker L, Vafidis G, While A, et al. Longterm results of treatment of central serous retinopathy—a preliminary report. Trans Ophthalmol Soc UK,1986,105:473-475.
|
[6] |
Ficker L, Vafidis G, While A, et al. Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol,1988, 72:829-834.
|
[7] |
Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol,1967,63:587-615.
|
[8] |
Baran NV, Gürlü VP, Esgin H. Long-term macular function in eyes with central serous chorioretinopathy. Clin Exp Ophthalmol,2005,33:369-372.
|
[9] |
Yap EY, Robertson DM. The long-term outcome of central serous chorioretinopathy. Arch Ophthalmol,1996,114:689-692.
|
[10] |
Castro-Correia J, Coutinho MF, Rosas V, et al. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol,1992,81:379-386.
|
[11] |
Brancato R, Scialdone A, Pece A, et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol,1987,225:166-168.
|
[12] |
Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina,2002, 22:25-32.
|
[13] |
Jumper JM. Central serous chorioretinopathy. Br J Ophthalmol,2003,87:663.
|
[14] |
Verma L, Sinha R, Venkatesh P, et al. Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial. BMC Ophthalmol,2004,4:15-22.
|
[15] |
毕燕龙,荣翱,李锦文. 微脉冲激光治疗中心性浆液性脉络膜视网膜病变的临床疗效. 中华眼底病杂志,2007,23:45-47.
|
[16] |
Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol,2003, 87:1453-1458.
|
[17] |
Schmidt-Erfurth U, Michels S, Barbazetto I, et al. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci,2002,43:830-841.
|
[18] |
Barcelona PF, Luna JD, Chiabrando GA, et al. Immunohistochemical localization of low density lipoprotein receptor-related protein 1 and alpha (2)-Macroglobulin in retinal and choroidal tissue of proliferative retinopathies. Exp Eye Res,2010,91:264-272.
|
[19] |
Schlötzer-Schrehardt U, Viestenz A, Naumann GO, et al. Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol,2002,240:748-757.
|
[20] |
Chan WM, Lam DS, Lai TY, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol,2003, 136:836-845.
|
[21] |
Ergun E, Tittl M, Stur M. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol,2004, 122:37-41.
|
[22] |
Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina,2003,23:288-298.
|
[23] |
Cardillo PF, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina ,2003,23: 752-763.
|
[24] |
Battaglia Parodi M, Da Pozzo S, Ravalico G. Photodynamic therapy in chronic central serous chorioretinopathy. Retina,2003,23:235-237.
|
[25] |
Ober MD, Yannuzzi LA, Do DV, et al. Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology,2005,112:2088-2094.
|
[26] |
Chan WM, Lai TY, Lai RY et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology,2008,115:1756-1765.
|
[27] |
Zhao MW, Zhou P, Xiao HX, et al. Photodynamic therapy for acute central serous chorioretinopathy: the safe effective lowest dosage of verteporfin. Retina,2009,29:1155-1161.
|